Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24e76490bed88751680a5fef9bc73892 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate |
2004-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28155835d39377c1ed2e91ea9f647e8a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f75b1a121e29831843f6185bb88d169d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8e3f08bdc23a1505d98a92f0661fda2 |
publicationDate |
2005-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2533126-A1 |
titleOfInvention |
Use of combination of an epidermal growth factor receptor kinase inhibitor and cytotoxic agents for treatment and inhibition of cancer |
abstract |
This invention discloses combinations comprising a cytotoxic agent and an EGFR kinase inhibitor, and methods of treating or inhibiting cancer in a mammal in I need thereof which comprises administering to said mammal an effective amount of a cytotoxic agent and an EGFR kinase inhibitor. |
priorityDate |
2003-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |